Counting Offit's Millions: More on How Merck's Rotateq Vacci

By Dan Olmsted and Mark Blaxill Paul Offit, vaccine entrepreneur and public health spokesperson, has earned approximately $10 million in income from Rotateq® royalties through 2009 and stands to earn a total of between $13-35 million over the life of...

Related Keywords

Philadelphia , Pennsylvania , United States , Nicaragua , American , Wyeth Rotashield , Tamy Wallace , Fred Clark , Jake Crosby , Russel Kaufman , Merck Rotateq , Wistar Rotateq , Paul Offit , Stanley Plotkin , Offit Rotateq , Staci Vernick Goldberg , Glaxosmithkline Rotarix , Merylej Melnicoff , Growth Of The Wistar Institute Licensing Income , Institute She , Wistar Institute Annual , Wistar Institute Technology , Council For Growth , Moody , Children Hospital Foundation , Moody Global Credit Research , Royalty Pharma , Paul Royalty Fund , Paul Capital The Royalty Fund , Wistar Institute , Business Development , Hospital Foundation , Global Credit Research , Inventor Share , Intellectual Property , Net Income , Autism Contributing Editor Jake Crosby , Applied Genomics , Paul Capital , Vernick Goldberg , Annual Rotateq , Annual Reports , Wired Magazine , Wall Street , Like Wistar , Total Payments , Mark Blaxill , Rotateq , Merck , Dan Olmsted , Royalties , Distar , Shop , Payments , Age Of Autism ,